{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T15:39:57Z","timestamp":1770910797790,"version":"3.50.1"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pompe disease results from a mutation in the acid \u03b1-glucosidase gene leading to lysosomal glycogen accumulation. Respiratory insufficiency is common, and the current U.S. Food and Drug Administration\u2013approved treatment, enzyme replacement, has limited effectiveness. Ampakines are drugs that enhance \u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor responses and can increase respiratory motor drive. Recent work indicates that respiratory motor drive can be blunted in Pompe disease, and thus pharmacologic stimulation of breathing may be beneficial. Using a murine Pompe model with the most severe clinical genotype (the Gaa\u2212\/\u2212 mouse), our primary objective was to test the hypothesis that ampakines can stimulate respiratory motor output and increase ventilation. Our second objective was to confirm that neuropathology was present in Pompe mouse medullary respiratory control neurons. The impact of ampakine CX717 on breathing was determined via phrenic and hypoglossal nerve recordings in anesthetized mice and whole-body plethysmography in unanesthetized mice. The medulla was examined using standard histological methods coupled with immunochemical markers of respiratory control neurons. Ampakine CX717 robustly increased phrenic and hypoglossal inspiratory bursting and reduced respiratory cycle variability in anesthetized Pompe mice, and it increased inspiratory tidal volume in unanesthetized Pompe mice. CX717 did not significantly alter these variables in wild-type mice. Medullary respiratory neurons showed extensive histopathology in Pompe mice. Ampakines stimulate respiratory neuromotor output and ventilation in Pompe mice, and therefore they have potential as an adjunctive therapy in Pompe disease.<\/jats:p>","DOI":"10.1165\/rcmb.2014-0374oc","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T12:44:26Z","timestamp":1420721066000},"page":"326-335","source":"Crossref","is-referenced-by-count":43,"title":["Stimulation of Respiratory Motor Output and Ventilation in a Murine Model of Pompe Disease by Ampakines"],"prefix":"10.1093","volume":"53","author":[{"given":"Mai K.","family":"ElMallah","sequence":"first","affiliation":[{"name":"Divisions of Pulmonary Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Pagliardini","sequence":"additional","affiliation":[{"name":"Department of Physiology, Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara M.","family":"Turner","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy, College of Public Health and Health Professions"},{"name":"McKnight Brain Institute, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony J.","family":"Cerreta","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy, College of Public Health and Health Professions"},{"name":"McKnight Brain Institute, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darin J.","family":"Falk","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Therapy, and"},{"name":"Pediatric Cardiology, Department of Pediatrics, College of Medicine"},{"name":"Powell Gene Therapy Center, University of Florida, Gainesville, Florida; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J.","family":"Byrne","sequence":"additional","affiliation":[{"name":"Cellular and Molecular Therapy, and"},{"name":"Pediatric Cardiology, Department of Pediatrics, College of Medicine"},{"name":"Powell Gene Therapy Center, University of Florida, Gainesville, Florida; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John J.","family":"Greer","sequence":"additional","affiliation":[{"name":"Department of Physiology, Neuroscience and Mental Health Institute, University of Alberta, Edmonton, Alberta, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David D.","family":"Fuller","sequence":"additional","affiliation":[{"name":"Department of Physical Therapy, College of Public Health and Health Professions"},{"name":"McKnight Brain Institute, and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2015,9,1]]},"reference":[{"key":"2026021122352342000_bib1","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021122352342000_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/1566524024605789","article-title":"Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease)","volume":"2","author":"Raben","year":"2002","journal-title":"Curr Mol Med"},{"key":"2026021122352342000_bib3","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1097\/NEN.0b013e3181815994","article-title":"Temporal neuropathologic and behavioral phenotype of 6neo\/6neo Pompe disease mice","volume":"67","author":"Sidman","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"2026021122352342000_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.resp.2013.06.007","article-title":"The respiratory neuromuscular system in Pompe disease","volume":"189","author":"Fuller","year":"2013","journal-title":"Respir Physiol Neurobiol"},{"key":"2026021122352342000_bib5","doi-asserted-by":"crossref","first-page":"R61","DOI":"10.1093\/hmg\/ddr174","article-title":"Pompe disease gene therapy","volume":"20","author":"Byrne","year":"2011","journal-title":"Hum Mol Genet"},{"key":"2026021122352342000_bib6","article-title":"The importance of targeting the central nervous system (CNS) for treatment of respiratory insufficiency in Pompe disease","author":"Fuller","year":"2013"},{"key":"2026021122352342000_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3389\/fphys.2011.00031","article-title":"Hypoglossal neuropathology and respiratory activity in Pompe mice","volume":"2","author":"Lee","year":"2011","journal-title":"Front Physiol"},{"key":"2026021122352342000_bib8","first-page":"147","article-title":"Language and speech function in children with infantile Pompe disease","volume":"7","author":"Muller","year":"2009","journal-title":"J Pediatr Neurol"},{"key":"2026021122352342000_bib9","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa0909859","article-title":"A randomized study of alglucosidase alfa in late-onset Pompe\u2019s disease","volume":"362","author":"van der Ploeg","year":"2010","journal-title":"N Engl J Med"},{"key":"2026021122352342000_bib10","doi-asserted-by":"crossref","first-page":"19086","DOI":"10.1074\/jbc.273.30.19086","article-title":"Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II","volume":"273","author":"Raben","year":"1998","journal-title":"J Biol Chem"},{"key":"2026021122352342000_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1073\/pnas.91.2.777","article-title":"Facilitation of glutamate receptors enhances memory","volume":"91","author":"Staubli","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026021122352342000_bib12","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0006-8993(94)90669-6","article-title":"A centrally active drug that modulates AMPA receptor gated currents","volume":"638","author":"Arai","year":"1994","journal-title":"Brain Res"},{"key":"2026021122352342000_bib13","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1164\/rccm.200606-778OC","article-title":"Ampakines alleviate respiratory depression in rats","volume":"174","author":"Ren","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021122352342000_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/clpt.2009.194","article-title":"Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia","volume":"87","author":"Oertel","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"2026021122352342000_bib15","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1152\/japplphysiol.00752.2012","article-title":"Respiratory depression in rats induced by alcohol and barbiturate and alleviation by ampakine CX717","volume":"113","author":"Ren","year":"2012","journal-title":"J Appl Physiol"},{"key":"2026021122352342000_bib16","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/ALN.0b013e318291079c","article-title":"Coadministration of the AMPAKINE CX717 with propofol reduces respiratory depression and fatal apneas","volume":"118","author":"Ren","year":"2013","journal-title":"Anesthesiology"},{"key":"2026021122352342000_bib17","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1097\/ALN.0b013e31819faa2a","article-title":"Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats","volume":"110","author":"Ren","year":"2009","journal-title":"Anesthesiology"},{"key":"2026021122352342000_bib18","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/mt.2013.282","article-title":"Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in Pompe mice","volume":"22","author":"Elmallah","year":"2014","journal-title":"Mol Ther"},{"key":"2026021122352342000_bib19","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/mt.2013.96","article-title":"Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease","volume":"21","author":"Falk","year":"2013","journal-title":"Mol Ther"},{"key":"2026021122352342000_bib20","doi-asserted-by":"crossref","first-page":"e8766","DOI":"10.1371\/journal.pone.0008766","article-title":"Opiate-induced suppression of rat hypoglossal motoneuron activity and its reversal by ampakine therapy","volume":"5","author":"Lorier","year":"2010","journal-title":"PLoS One"},{"key":"2026021122352342000_bib21","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1152\/jn.00399.2009","article-title":"Phrenic motoneuron discharge patterns during hypoxia-induced short-term potentiation in rats","volume":"102","author":"Lee","year":"2009","journal-title":"J Neurophysiol"},{"key":"2026021122352342000_bib22","doi-asserted-by":"crossref","first-page":"9575","DOI":"10.1523\/JNEUROSCI.23-29-09575.2003","article-title":"Ontogeny of the pre-B\u00f6tzinger complex in perinatal rats","volume":"23","author":"Pagliardini","year":"2003","journal-title":"J Neurosci"},{"key":"2026021122352342000_bib23","doi-asserted-by":"crossref","first-page":"11030","DOI":"10.1523\/JNEUROSCI.1648-08.2008","article-title":"Central respiratory rhythmogenesis is abnormal in Lbx1-deficient mice","volume":"28","author":"Pagliardini","year":"2008","journal-title":"J Neurosci"},{"key":"2026021122352342000_bib24","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.1683005","article-title":"Pre-B\u00f6tzinger complex: a brainstem region that may generate respiratory rhythm in mammals","volume":"254","author":"Smith","year":"1991","journal-title":"Science"},{"key":"2026021122352342000_bib25","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.286.5444.1566","article-title":"Modulation of respiratory frequency by peptidergic input to rhythmogenic neurons in the preB\u00f6tzinger complex","volume":"286","author":"Gray","year":"1999","journal-title":"Science"},{"key":"2026021122352342000_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/cne.10504","article-title":"A group of glutamatergic interneurons expressing high levels of both neurokinin-1 receptors and somatostatin identifies the region of the pre-B\u00f6tzinger complex","volume":"455","author":"Stornetta","year":"2003","journal-title":"J Comp Neurol"},{"key":"2026021122352342000_bib27","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1523\/JNEUROSCI.4930-04.2005","article-title":"Fluorescent tagging of rhythmically active respiratory neurons within the pre-B\u00f6tzinger complex of rat medullary slice preparations","volume":"25","author":"Pagliardini","year":"2005","journal-title":"J Neurosci"},{"key":"2026021122352342000_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00115-005-2005-7","article-title":"Glycogenesis type II (M. Pompe): selective failure of the respiratory musculature\u2014a rare first symptom [in German]","volume":"77","author":"Burghaus","year":"2006","journal-title":"Nervenarzt"},{"key":"2026021122352342000_bib29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.rmed.2008.12.009","article-title":"Pompe disease: a neuromuscular disease with respiratory muscle involvement","volume":"103","author":"Mellies","year":"2009","journal-title":"Respir Med"},{"key":"2026021122352342000_bib30","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1212\/01.WNL.0000158682.85052.C0","article-title":"Respiratory failure in Pompe disease: treatment with noninvasive ventilation","volume":"64","author":"Mellies","year":"2005","journal-title":"Neurology"},{"key":"2026021122352342000_bib31","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1183\/09031936.05.00020005","article-title":"Respiratory insufficiency and limb muscle weakness in adults with Pompe\u2019s disease","volume":"26","author":"Pellegrini","year":"2005","journal-title":"Eur Respir J"},{"key":"2026021122352342000_bib32","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"key":"2026021122352342000_bib33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1469-8749.2003.tb00966.x","article-title":"Pompe disease and physical disability","volume":"45","author":"Haley","year":"2003","journal-title":"Dev Med Child Neurol"},{"key":"2026021122352342000_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.GIM.0000154301.76619.5C","article-title":"Infantile onset Pompe disease: a report of physician narratives from an epidemiologic study","volume":"7","author":"Marsden","year":"2005","journal-title":"Genet Med"},{"key":"2026021122352342000_bib35","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1212\/01.WNL.0000165979.46537.56","article-title":"Disease severity in children and adults with Pompe disease related to age and disease duration","volume":"64","author":"Hagemans","year":"2005","journal-title":"Neurology"},{"key":"2026021122352342000_bib36","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1378\/chest.105.3.947","article-title":"Obstructive sleep apnea syndrome in acid maltase deficiency","volume":"105","author":"Margolis","year":"1994","journal-title":"Chest"},{"key":"2026021122352342000_bib37","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/ajmg.a.36227","article-title":"Polysomnographic findings in infantile Pompe disease","volume":"161A","author":"Kansagra","year":"2013","journal-title":"Am J Med Genet A"},{"key":"2026021122352342000_bib38","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2147\/TCRM.S5776","article-title":"Alglucosidase alfa: long term use in the treatment of patients with Pompe disease","volume":"5","author":"Beck","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"2026021122352342000_bib39","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s10354-012-0153-5","article-title":"Respiratory function in late-onset Pompe disease patients receiving long-term enzyme replacement therapy for more than 48 months","volume":"163","author":"Schneider","year":"2013","journal-title":"Wien Med Wochenschr"},{"key":"2026021122352342000_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2011.02.004","article-title":"Pompe disease: design, methodology, and early findings from the Pompe Registry","volume":"103","author":"Byrne","year":"2011","journal-title":"Mol Genet Metab"},{"key":"2026021122352342000_bib41","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1007\/s00415-012-6636-x","article-title":"Enzyme replacement therapy in late-onset Pompe disease: a systematic literature review","volume":"260","author":"Toscano","year":"2013","journal-title":"J Neurol"},{"key":"2026021122352342000_bib42","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1542\/peds.113.5.e448","article-title":"Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk","volume":"113","author":"Van den Hout","year":"2004","journal-title":"Pediatrics"},{"key":"2026021122352342000_bib43","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.nmd.2011.04.001","article-title":"Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease","volume":"21","author":"Orlikowski","year":"2011","journal-title":"Neuromuscul Disord"},{"key":"2026021122352342000_bib44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1172\/JCI1722","article-title":"Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase\u2013deficient quail","volume":"101","author":"Kikuchi","year":"1998","journal-title":"J Clin Invest"},{"key":"2026021122352342000_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ymgme.2003.08.022","article-title":"Enzyme replacement therapy in the mouse model of Pompe disease","volume":"80","author":"Raben","year":"2003","journal-title":"Mol Genet Metab"},{"key":"2026021122352342000_bib46","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/138945007780618490","article-title":"Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior","volume":"8","author":"Arai","year":"2007","journal-title":"Curr Drug Targets"},{"key":"2026021122352342000_bib47","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1371\/journal.pbio.0030299","article-title":"Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates","volume":"3","author":"Porrino","year":"2005","journal-title":"PLoS Biol"},{"key":"2026021122352342000_bib48","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/0269881111405353","article-title":"Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep","volume":"26","author":"Boyle","year":"2012","journal-title":"J Psychopharmacol"},{"key":"2026021122352342000_bib49","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1152\/jn.1965.28.3.599","article-title":"Excitability and inhibitability of motoneurons of different sizes","volume":"28","author":"Henneman","year":"1965","journal-title":"J Neurophysiol"},{"key":"2026021122352342000_bib50","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1152\/ajplegacy.1971.221.2.535","article-title":"Relationship between phrenic nerve activity and ventilation","volume":"221","author":"Eldridge","year":"1971","journal-title":"Am J Physiol"},{"key":"2026021122352342000_bib51","first-page":"290","article-title":"Respiratory drive and timing in chronic obstructive pumonary disease","volume":"73","author":"Grassino","year":"1978","journal-title":"Chest"},{"key":"2026021122352342000_bib52","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1164\/rccm.201206-1072OC","article-title":"Intermittent hypoxia and stem cell implants preserve breathing capacity in a rodent model of amyotrophic lateral sclerosis","volume":"187","author":"Nichols","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026021122352342000_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.resp.2014.03.005","article-title":"Neither serotonin nor adenosine-dependent mechanisms preserve ventilatory capacity in ALS rats","volume":"197","author":"Nichols","year":"2014","journal-title":"Respir Physiol Neurobiol"},{"key":"2026021122352342000_bib54","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.pediatrneurol.2010.02.006","article-title":"Acute progression of neuromuscular findings in infantile Pompe disease","volume":"42","author":"Burrow","year":"2010","journal-title":"Pediatr Neurol"},{"key":"2026021122352342000_bib55","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/hum.2012.250","article-title":"Phase I\/II trial of AAV1-GAA gene therapy to the diaphragm for chronic respiratory failure in Pompe disease: initial safety and ventilatory outcomes","volume":"24","author":"Smith","year":"2013","journal-title":"Hum Gene Ther"}],"container-title":["American Journal of Respiratory Cell and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/53\/3\/326\/66832869\/ajrcmb_53_3_326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article-pdf\/53\/3\/326\/66832869\/ajrcmb_53_3_326.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T03:38:19Z","timestamp":1770867499000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrcmb\/article\/53\/3\/326\/8467963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,1]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,9,1]]},"published-print":{"date-parts":[[2015,9,1]]}},"URL":"https:\/\/doi.org\/10.1165\/rcmb.2014-0374oc","relation":{},"ISSN":["1044-1549","1535-4989"],"issn-type":[{"value":"1044-1549","type":"print"},{"value":"1535-4989","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,9]]},"published":{"date-parts":[[2015,9,1]]}}}